Sunday, December 06, 2020 5:16:45 PM
1. https://www.sec.gov/Archives/edgar/data/1701251/000167025417000251/document_11.pdf
*See Slide 9
2. Google "Fuzeon" from slide 9. It is a peptide drug similar to clone 3 that ENZC is developing, but far less effective.
3. Who owns Fuzeon you might ask? Genentech. Who went on to get acquired by Roche Holdings for $47B, ticker = RHHBY. It now trades for $43.68...
How much will people pay for a treatment over twice as effective?
Get comfortable folks. This is only the beginning.
All of my posts are opinion. Do your own due diligence, I provide no financial advice.
Recent ENZC News
- Small Cap Recipient of Military Drone Technology • InvestorsHub NewsWire • 11/20/2023 01:14:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM